Must an 80-year-old elderly person with atrial fibrillation take rivaroxaban tablets?

Rivaroxaban tablets are a novel oral anticoagulant used to prevent stroke and systemic embolism in patients with atrial fibrillation. For an 80-year-old patient with atrial fibrillation, if the individual is at low risk, rivaroxaban may not be necessary; however, if the patient is at high risk, taking rivaroxaban as directed by a physician is recommended. Any discomfort should prompt timely medical consultation. The detailed analysis is as follows:

If the elderly patient belongs to a low-risk group, long-term use of rivaroxaban may not be required, as their risk of stroke is relatively low. In such cases, the potential bleeding risks associated with long-term anticoagulation therapy, such as with rivaroxaban, may outweigh the benefits in stroke prevention. Physicians might consider non-pharmacological interventions or short-term observation rather than directly recommending prolonged anticoagulant therapy.

If the elderly patient is in a high-risk group—especially those with a history of prior stroke, hypertension, heart failure, or other comorbidities—their risk of stroke is significantly increased. Anticoagulants like rivaroxaban work by inhibiting thrombin activity, reducing the formation of blood clots, thereby effectively lowering the risk of stroke in these patients.

In addition to medication, elderly patients should also ensure adequate rest, avoid strenuous exercise, and maintain a light diet to reduce cardiac strain and support recovery.